Related Experiment Video
Updated: Jan 23, 2026

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
Published on: October 21, 2022
Intragenic antagonistic roles of protein and circRNA in tumorigenesis
Jlenia Guarnerio1,2, Yang Zhang1, Giulia Cheloni1
1Cancer Research Institute, Beth Israel Deaconess Cancer Center, Departments of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
Abstract:
circRNAs arise from back splicing events during mRNA processing, and when deregulated can play an active role in cancer. Here we characterize a new circRNA (circPOK) encoded by the Zbtb7a gene (also kown as POKEMON, LRF) in the context of mesenchymal tumor progression. circPOK functions as a non-coding proto-oncogenic RNA independently and antithetically to its linear transcript counterpart, which acts as a tumor suppressor by encoding the Pokemon transcription factor. We find that circPOK regulates pro-proliferative and pro-angiogenic factors by co-activation of the ILF2/3 complex. Importantly, the expression of Pokemon protein and circRNA is aberrantly uncoupled in cancer through differential post-transcriptional regulation. Thus, we identify a novel type of genetic unit, the iRegulon, that yields biochemically distinct RNA products, circular and linear, with diverse and antithetical functions. Our findings further expand the cellular repertoire towards the control of normal biological outputs, while aberrant expression of such components may underlie disease pathogenesis including cancer.
Insights
A novel circular RNA, circPOK, acts as a cancer-promoting oncogene, distinct from its tumor-suppressing linear counterpart. This discovery reveals a new regulatory unit, the iRegulon, with opposing functions in cancer.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Circular RNAs (circRNAs) are emerging regulators in cancer development.
- The Zbtb7a gene produces both linear (Pokemon protein) and circular (circPOK) RNA transcripts.
- Aberrant circRNA expression is linked to various pathologies, including cancer.
Purpose of the Study:
- To characterize the novel circRNA, circPOK, derived from the Zbtb7a gene.
- To elucidate the distinct functions of circPOK and its linear counterpart in mesenchymal tumors.
- To identify novel regulatory mechanisms in cancer pathogenesis.
Main Methods:
- RNA sequencing and bioinformatics analysis to identify and characterize circPOK.
- Functional assays to determine the oncogenic role of circPOK.
- Investigation of circPOK's interaction with the ILF2/3 complex.
- Analysis of Pokemon protein and circPOK expression in cancer tissues.
Main Results:
- circPOK functions as a non-coding RNA with proto-oncogenic activity in mesenchymal tumors.
- circPOK promotes proliferation and angiogenesis by co-activating the ILF2/3 complex.
- Pokemon protein, encoded by the linear transcript, acts as a tumor suppressor.
- Expression of Pokemon protein and circPOK is uncoupled in cancer due to differential post-transcriptional regulation.
Conclusions:
- A novel genetic unit, the iRegulon, generates distinct circular and linear RNA products with opposing functions.
- circPOK represents a new class of oncogenic circRNAs.
- Aberrant expression of iRegulons contributes to disease pathogenesis, highlighting new therapeutic targets.
More Related Videos
06:02A Computational Pipeline for Intergenic/Intragenic Enhancer RNA Quantification in Mouse Embryonic Stem Cells
Published on: October 28, 2025
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
Related Concept Videos
Role of Proteins in the Human Body
Cholinergic Antagonists: Pharmacokinetics
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Antiepileptic Drugs: Glutamate Antagonists